Pascal Soriot
| Use attributes for filter ! | |
| Gender | Male |
|---|---|
| Age | 65 |
| Date of birth | May 23,1959 |
| Zodiac sign | Gemini |
| Born | France |
| Salary | compensation |
| Alma maters | École nationale vétérinaire d'Alfort |
| HEC Paris | |
| Job | Businessperson |
| Education | HEC Paris |
| École nationale vétérinaire d'Alfort | |
| Alfort National Veterinary School | |
| Titl | AstraZeneca |
| Nationality | Australian |
| French | |
| Full name | Pascal Claude Roland Soriot |
| Children | 2 |
| Honour | Knight Bachelor |
| Date of Reg. | |
| Date of Upd. | |
| ID | 402910 |
Pascal Soriot Life story
Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive officer of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.
Big firm bosses' pay rose 16% as workers squeezed
... According to the High Pay Centre s research, the highest paid chief executive last year was Sir Pascal Soriot, the boss of the drugs giant AstraZeneca, with £15...
Covid: No vaccine passport expansion in Scotland and new advice in Northern Ireland
... Pascal Soriot told BBC Radio 4 s Today programme that unlike much of Europe, the UK had used the AstraZeneca vaccine on many older people...
Covid-19: UK bucks Europe trend, and AstraZeneca to draw jab profits
... AstraZeneca chief executive Pascal Soriot says the disease is becoming endemic in society...
AstraZeneca to take profits from Covid vaccine
... Its chief executive Pascal Soriot said the disease was becoming endemic...
Corona Virus vaccine: AstraZeneca increases potential 2 billion
... AstraZeneca, Pascal Soriot, chief executive, said he expects to know by August, when the AZD1222 vaccine is effective, while CEPI chief executive Richard Hatchett said that there is still a possibility the vaccine may not work...
Coronavirus: How England is lagging behind other UK Nations to the test
... we believe that We will begin testing until mid-April, AstraZeneca CEO Pascal Soriot, the BBC, the Today programme said, and be on a large scale with 30,000 tests per day at the beginning of may...
AstraZeneca to take profits from Covid vaccine
AstraZeneca has started to Move Away from providing its Covid-19 vaccine to countries at cost.
The drugs giant has signed a series of for-profit agreements for next year, and expects to make a modest profit from the vaccine this quarter, it said.
The Company had previously said it would only start to make money from the vaccine when Covid-19 was no longer a pandemic.
Its chief executive Pascal Soriot said the disease was becoming endemic.
The jab will continue to be supplied not-for-profit to poorer countries.
Other vaccine manufacturers including Pfizer and Moderna have been making profits from their vaccines.
In its financial results, AstraZeneca said, " The Company is now expecting to progressively transition the vaccine to modest profitability as new orders are received.
It said: " Covid-19 vaccine sales in [The Fourth quarter of 2021] are expected to be a blend of the original pandemic agreements and new orders, with the large majority coming from pandemic agreements. "
Mr Soriot had previously said, " We decided to provide it at no profit, because our top priority was to protect global health. "
He told The Bbc he had " absolutely no regrets" about not making a profit when competitors had been, despite having to deal with political criticism in various countries.
He Said the vaccine had saved A Million lives around The World .
By The End of September, AstraZeneca and its sub-licensees had supplied 1. 5 billion doses.
Source of news: bbc.com
Pascal Soriot Photos
